Allergy testing in children: Why, who, when and how?

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 58, Issue 7, 2003, Pages 559-569

  Host A ^a   Andrae, S ^b   Charkin, S ^b   Diaz Vazquez C ^b   Dreborg, S ^b   Eigenmann, P A ^b   Friedrichs, F ^b   Grinsted, P ^b   Lack, G ^b   Meylan, G ^b   Miglioranzi, P ^b   Muraro, A ^b   Nieto, A ^b   Niggemann, B ^b   Pascual, C ^b   Pouech, M G ^b   Rance F ^b   Rietschel, E ^b   Wickman, M ^b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGY VACCINE; ANTIALLERGIC AGENT; HISTAMINE; IMMUNOGLOBULIN E; UNCLASSIFIED DRUG; VACCINE;

ALLERGIC ASTHMA; ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ALLERGY; ALLERGY TEST; ATOPIC DERMATITIS; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CROSS REACTION; FOOD ALLERGY; HISTAMINE RELEASE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; NOTE; PATCH TEST; PREVALENCE; PRICK TEST; PRIORITY JOURNAL; SKIN TEST; VACCINATION;

ANTIBODY SPECIFICITY; CHILD; CHILD WELFARE; CHILD, PRESCHOOL; CLINICAL TRIALS; EVIDENCE-BASED MEDICINE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOLOGIC TESTS; INFANT; PREVALENCE;

EID: 0242607568     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2003.00238.x     Document Type: Note

References (115)

1. ECCLES M, FREMANTLE N, MASON J. North of England based guidelines development project: methods of developing guidelines for efficient drug use in primary care. Eduction and debate. BMJ 1998;316:1232-1235. IV
2. HARBOUR R, MILLER J. A new system for grading recommendations in evidence-based guidelines. BMJ 2001;323(7308):334-6. IV
3. Bandolier Library. Bias in diagnostic testing. Levels of evidence. http://www.jr2.ox.ac.uk/bandolier/booth/diagnosis/bias.html (accessed 12 February 2003) IV
4. Oxford Centre for Evidence-based Medicine. Levels of Evidence and Grades of Recommendations. Updated May 2001. www.Indigojazz.co/uk/cebm/levels_of_evidence.asp (accessed 12 February 2003) IV
5. SLY RM. Changing prevalence of allergic rhinitis and asthma. Ann Allergy Asthma Immunol 1999;82:233-248. IV
6. DOWNS SH, MARKS GB, SPORIK R, BELOSOUVA EG, CAR NG, PEAT JK. Continued increase in the prevalence of asthma and atopy. Arch Dis Child 2001;84:20-23. III
7. BURR MK, BUTLAND BK, KING S, VAUGHAN-WILLIAMS E. Changes in asthma prevalence: two surveys 15 years apart. Arch Dis Child 1989;64:1454-1456. III
8. MAGNUS P, JAAKKOLA JJ. Secular trend in the occurrence of asthma among children and young adults: critical aparisal of repeated cross sectional surveys. BMJ 1997;314:1795-1799. IV
9. SCHULTZ LF. Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1993;28:719-723. III
10. SCHULTZ LF, DIEPGEN T, SVENSSON A. The occurrence of atopic dermatitis in north Europe: an international questionnaire study. J Am Acad Dermatol 1996;34:760-764. III
11. SCHULTZ LF. Atopic dermatitis: an increasing problem. Pediatr Allergy Immunol 1996;7:51-53. IV
12. HØST A, HALKEN S. The role of allergy in childhood asthma. Allergy 2000;55:600-608. IV
13. WAHN U. What drives the allergic march? Allergy 2000;55:591-599. IV
14. HALKEN S, HØST A. The lessons of noninterventional and interventional prospective studies on the development of atopic disease during childhood. Allergy 2000;55:793-802. IV
15. TRINDADE JC. The importance of diagnosis of allergy in early wheezing. Pediatr Allergy Immunol 1998;9:23-29. IV
16. HATTEVIG G, KJELLMAN B, JOHANSSON SG, BJORKSTEN B. Clincial symptoms and IgE responses to common food proteins in atopic and healthy children. Clin Allergy 1984;14:551-559. II
17. HØST A, HALKEN S. A prospective study of cow milk allergy in Danish infants during the first 3 years of life. Clinical course in relation to clinical and immunological type of hypersensitivity reaction. Allergy 1990;45:587-596. II
18. NICKEL R, KULIG M, FORSTER J et al. Sensitization to hen's egg at the age of twelve months is predictive for allergic sensitization to common indoor and outdoor allergens at the age of three years. J Allergy Clin Immunol 1997;99:613-617. II
19. BASAI K, FURUKAWA S, MUTO T, BABA M, YABUTA K, EUKUWUTARI Y. Early detection of specific IgE antibody against house dust mite in children at risk of allergic disease. J Pediatr 1996;128:834-840. II
20. HATTEVIG G, KJELLMAN B, BJÖRKSTĖN B. Clinical symptoms and IgE responses to common food protein and inhalants in the first 7 years of life. Clin Allergy 1987;17:571-580. II
21. JOHANSSON SG, HOURIHANE JO, BOUSQUET J et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56:813-824. IV
22. O'BYRNE PM, DOLOVICH J, HARGREAVE FE. Late asthmatic responses. Am Rev Dis 1987;136(3):740-751. II
23. DURHAM SR, CRADDOCK CF, COOKSON WO, BENSON MK. Increases in airway responsiveness to histamine precede allergen-induced late asthmatic responses. J Allergy Clin Imunol 1988;82(5 Pt 1):764-70. III
24. DREBORG S. Impact of allergen exposure on bronchial hyperresponsiveness. Pediatr Allergy Immunol 1996;(9 Suppl):14-7. IV
25. BONER AL, NIERO E, ANTOLINI I, VALETTA EA. Pulmonary function and bronchial hyperreactivity in asthmatic children with house dust mite allergy during prolonged stay in the Italian Alps (Misurini 1756 m). Ann Allergy 1985;54:42-5. II
26. PIACENTINI GL, VINCENTINI L, MAZZI P, CHILOSI M, MARTINATI L, BONER AL. Mite-antigen avoidance can reduce bronchial epithelial shedding in allergic asthmatic children. Clin Exp Allergy 1998;28:561-7. II
27. PIACENTINI GL, MARTINATI L, MINGONI S, BONER AL. Influence of allergen avoidance on the eosinophil phase of airway inflammation in children with asthmatic asthma. J Allergy Clin Immunol 1996;97:1079-84. II
28. PIACENTINI GL, MARTINATI L, FORNARI A, COMIS A, CARCERERI L, BOCCAGNI P et al. Antigen avoidance in a mountain environment: Influence on basophil releasability in children with allergic asthma. J Allergy Clin Immunol 1993;92:644-50. II
29. GROOTENDORST DC, DAHLEN SE, VAN DEN BOS JW, DUIVERMAN EJ, VESELIC-CHARVAT M, VRIJLANDT EJ et al. Benefits of high altitude allergen avoidance in atopic adolescents with moderate to severe asthma, over and above treatment with high dose inhaled steroids. Clin Exp Allergy 2001;31(3):400-8. II
30. NISHIOKA K, YASUEDA H, SAITO H. Preventive effect of bedding encasement with microfine fibers on mite sensitization. J Allergy Clin Immunol 1998;101(1 Pt 1):28-32. II
31. HARVING H, KORSGAARD J, DAHL R. Clinical efficacy of reduction in house-dust mite exposure in specially designed, mechanically ventilated "healthy" homes. Allergy 1994;49(10):866-70. II
32. WICKMAN M, NORDVALL SL, PERSHAGEN G, KORSGAARD J, JOHANSEN N, SUNDELL J. Mite allergens during 18 months of intervention. Allergy 1994;49(2):114-9. II
33. EHNERT B, LAU-SCHADENDORF S, WEBER A, BUETTNER P, SCHOU C, WAHN U. Reducing domestic exposure to dust mite allergen reduces bronchial hyperreactivity in sensitive children with asthma. J Allergy Clin Immunol 1992;90(I):135-8. II
34. MARKS GB, TOVEY ER, GREEN W, SHEARER M, SALOME CM, WOOLCOCK AJ. House dust mite allergen avoidance: a randomized controlled trial of surface chemical treatment and encasement of bedding. Clin Exp Allergy 1994;24(11):1078-83. II
35. MARKS GB, TOVEY ER, TOELLEE BG, WACHINGER S, PEAT JK, WOOLCOCK AJ. Mite allergen (Der p I) concentration in houses and its relations to the presence and severity of asthma in a population of Sydney schoolchildren. J Allergy Clin Immunol 1995;96(4):441-8. II
36. MARKS GB, TOVEY ER, GREEN W, SHEARER M, SALOME CM, WOLLCOCK AJ. The effect of changes in house dust mite allergen exposure on the severity of asthma. Clin Exp Allergy 1995;25(2):114-8. II
37. WEEKS J, OLIVER J, BIRMINGHAM K, CREWES A, CARSWELL F. A combined approach to reduce mite allergen in the bedroom. Clin Exp Allergy 1995;25(12):1179-83. II
38. TAN BB, WEALD D, STRICKLAND I, FRIEDMANN PS. Double-blind controlled trial of effect of house dust-mite allergen avoidance on atopic dermatitis. Lancet 1996;347(8993):15-8. I
39. CARSWELL F, BIRMINGHAM K, OLIVER J, CREWES A, WEEKS J. The respiratory effects of reduction of mite alelrgen in the bedrooms of asthmatic children - a double-blind controlled trial. Clin Exp Allergy 1996;26(4):386-96. I
40. HALKEN S, HOST A, NIKLASSEN U, HANSEN LG, NIELSEN F, PEDERSEN S, ØSTERBALLE O, VEGGERBY C, POULSEN LK. Effect of mattress and pillow encasings on children with asthma and house dust mite allergy. J Allergy Clin Immunol 2003;111(1):169-76. I
41. FREDERICK JM, WARNER JO, JESSOP WJ, ENANDER I, WARNER JA. Effect of a bed covering system in children with asthma and house dust mite hypersensitivity. Eur Respir J 1997;10(2):361-6. II
42. VAN DER HEIDE S, KAUFFMAN HF, DUBOIS AE, de MONCHY JG. Allergen reduction measures in houses of allergic asthmatic patients: effects of air-cleaners and allergen-impermeable mattress covers. Eur Respir J 1997;10(6):1217-23. II
43. SHAPIRO GG, WIGHTON TG, CHINN T, ZUCKMAN J, ELIASSEN AH, PICCIANO JF et al. House dust mite avoidance for children with asthma in homes of low-income families. J Allergy Clin Immunol 1999;103(6):1069-74. II
44. CLOOSTERMAN SG, SCHERNER TR, BIJL-HOFLAND ID, VAN DER HS, BRUNEKREEF B, VAN DEN ELSHOUT FJ et al. Effects of house dust mite avoidance measures on Der p 1 concentrations and clinical condition of mild adult house dust mite-allergic asthamtic patients, using no inhaled steroids. Clin Exp Allergy 1999;29(10):1336-46. II
45. WARNER JA, FREDERICK JM, BRYANT TN, WEICH C, HUNTER C, STEPHEN FR et al. Mechanical ventilation and high-efficiency vacuum cleaning: A combined strategy of mite and mite allergen reductionin the control of mite-sensitive asthma. J Allergy Clin Immunol 2000;105:75-82. II
46. VANLAAR CH, PEAT JK, MARKS GB, RIMMER J, TOVEY ER. Domestic control of huse dust mite allergen in children's beds. J Alelrgy Clin Immunol 2000;105(6 Pt 1):1130-3. IV
47. CARSWELL F, OLIVER J, WEEKS J. Do mite avoidance measures affect mite and cat airborne allergens? Clin Exp Allergy 1999;29(2):193-200. III
48. HOLM L, OHMAN S, BENGTSSON A, HAGE-HAMSTEN M, SCHEYNIUS A. Effectiveness of occlusive bedding in the treatment of atopic dermatitis - a placebo-controlled trial of 12 months' duration. Allergy 2001;56(2):152-8. II
49. GOTZSCHE PC, JOHANSEN HK, BURR M, HAMMARQUIST C. House dust mite control measures for asthma. Cochrane Database Syst Rev 2002;3:CD001187. I
50. Global Strategy for Asthma Management and Prevention. National Institute of Health, National Heart, Lung, and Blood Institute. Revised 2002;www.ginasthma.com.
51. BOUSQUET J and the ARIA Workshop Group. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(5):147-334.I
52. ABRAMSON R, PUY R, WEINER JM. Immunotherapy in asthma: an updated systematic review. Allergy 1999;54:1022-41. I
53. VARNEY VA, HAMID QA, GAGA, M, YING S, JACOBSON M, FREW AJ et al. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest 1993;92(2):644-51. III
54. ABRAMSON MJ, PUY RM, WEINER JM. Allergen immunotherapy for asthma. Cochrane Database Syst Rev 2000;(2):CD001186. I
55. MOLLER C, DREBORG S, FERDOUISI HA, HALLKEN S, HOST A, JACOBSEN L et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 2002;109(2):251-6. II
56. DES ROCHES AD, PARADI L, MENARDO JL, BOUGES S, DAURÉS J-P, BOUSQUET J. Immunotherapy with a standardized dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 1997;99:450-3. II
57. MALLING HJ, ABREU-NOGUEIRA J, ALVAREZ-CUESTA E, BJORKSTEN B, BOUSQUET J, CAILLOT D, CANONICA GW, PASSALACQUA G, SAXONIS-PAPAGEORGIOU P, VALOVIRTA E. Local Immunotherapy. Allergy 1998;53(10):933-944. IV
58. IIKURA Y, NASPITZ CM, MIKAWA H et al. Prevention of asthma by ketotifen in infants with atopic dermatitis. Ann Allergy 1992;68:233-6. II
59. WAHN U, ETAC Study Group. Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: First results of ETAC. Pediatr Allergy Immunol 1998;9:116-24. I
60. BUSTOS GJ, BUSTOS D, BUSTOF GJ, ROMERO O. Prevention of asthma wit ketotifen in preasthmatic children: a three-year follow-up study. Clin Exp Allergy 1995;25(6):568-73. II
61. RESANO A, CRESPO E, FERNANDEZ BENTIEZ M et al. Atopic dermatitis and food allergy. J Investig Allergol Clin Immunol 1998;8:271-6. III
62. BOHME M, SVENSSON A, KULL I et al. Clinical features of atopic dermatitis at two years of age: a prospective populations-based case-control study. Acta Derm Venereol 2001;81:193-7. II
63. BURKS AW, JAMES JM, HIEGEL A et al. Atopic dermatitis and food hypersensivitiy reactions. J Pediatr 1998;132:132-6. II
64. EIGENMANN PA, SICHERER SH, BORKOWSKI TA et al. Prevalence of IgE-mediated food allergy among children with atopic dermatitis. Pediatr 1998;103:E8. III
65. SICHERER SH, SAMPSON HA. Food hypersensitivity and atopic dermatitis: pathophysiology, epidemiology, diagnosis and management. J Allergy Clin Immunol 1999;104:S114-22. IV
66. WOLKERSTORFER A, WAHN U, KJELLMAN NIM et al. Natural course of sensitization to cow's milk and hen's egg in childhood atopic dermatitis: ETAC study group. Clin Exp Allergy 2002;32:70-3. III
67. EIGENMANN PA, CALZA AM. Diagnosis of IgE-mediated food allergy among Swiss children with atopic dermatitis. Pediatr Allergy Immunol 2000;11:95-100. III
68. SILVESTRI M, ODDERA S, ROSSA GA et al. Sensitization to airborne allergens in children with respiratory symptoms. Ann Allergy Asthma Immunol 1996;76:239-44. III
69. CRIMI P, MINALE P, TAZZER C et al. Asthma and rhinitis in schoolchildren: the impact of allergic sensitization to aeroallergens. J Invest Allergol Clin Immunol 2001;11:103-6. III
70. BOULET L-P, TURCOTTE H, LAPRISE C et al. Comparative degree and type of sensitization to common indoor allergens in subjects with allergic rhinitis and/or asthma. Clin Exp Allergy 1995;27:52-59. III
71. MARTINEZ MD, WRIGHT AL, TAUSSIG LM et al. Asthma and wheezing in the first six years of life. N Engl J Med 1995;332:133-138. II
72. HABY MM, PEAK JK, MARKS GB et al. Asthma in pre-school children: prevalence and risk factors. Thorax 2001;56:589-95. II
73. TARIQ SM, MATTHEWS SM, HAKIM EA et al. The prevalence of and risk factors for atopy in early childhood: a whole population birth cohort study. J Allergy Clin Immunol 1998;101:587-93. II
74. MORTZ CG, LAURITSEN JM, BINDSLEV-JENSEN C et al. Prevalence of atopic dermatitis, asthma, allergic rhinitis and hand and contact dermatitis in adolescents. The Odense Adolescence Cohort Study on Atopic Diseases and Dermatitis. Brit J Dermatol 2001;144:523-32. III
75. ANNUS T, BJORKSTEN B, MAI Z' XM et al. Wheezing in relation to atopy and environmental factors in Estonian and Swedish school children. Clin Exp Allergy 2001;31:1846-53. III
76. GOLD DR, BURGE HA, CAREY V et al. Predictors of repeated wheeze in the first year of life. Am J Respir Crit Care Med 1999;160:227-36. III
77. HATTEVIG G, KJELLMAN B, BJÖRKSTEN B et al. The prevalence of allergy and IgE antibodies to inhalant allergens in Swedish schoolchildren. Acta Paediatr Scand 1987;76:349-55, III
78. PEARCE N, PEKKANEN J, BEASLEY R. How much asthma is really attributable to atopy? Thorax 1999;54:268-72. IV
79. PONSONBY AL, GATENBY P, GLASGOW N et al. Which clinical subgroups within the spectrum of child asthma are attributable to atopy? Chest 2002;121:135-42. III?
80. SEARS MR, BURROWS B, HERBISON GP et al. Atopy in childhood. II. Relationship to airway responsiveness, hay fever and asthma. Clin Exp Allergy 1993;23:949-56. II
81. TARIQ SM, MATTHEWS SM, HAKIM EA et al. The prevalence of and the risk of atopy in early childhood: a whole population birth cohort study. J Allergy Clin Immunol 1998;101:587-93. II
82. BERGER WE. Allergic rhinitis in children. Curr Allergy Asthma Reports 2001;1:498-505. III
83. MÜLLER UR. Hymenoptera venom hypersensitivity: an update. Clin Exp Allergy 1998;28:4-6. II
84. SALKIN AR, CUDDY PG, FOXWORTH JW. The rational clinical examination. Is this patient allergic to penicillin? An evidence-based analysis of the likelihood of penicillin allergy. JAMA 2001;285:2498-505. II
85. BREHLER R, KUTTING B. Natural rubber latex allergy. Arch Intern Med 2001;161:1057-1064. IV
86. BRUIJNZEEL-KOOMEN CAFM, ORTOLANI C, AAS K et al. Adverse reactions to foods: position paper. Allergy 1995;50:623-635. IV
87. DREBORG S. Skin tests used in type I allergy skin testing. Position paper prepared by the Subcommittee on Skin Tests of the European Academy of Allergology and Clinical Immunology. Allergy 1989;44(suppl):22-59. IV
88. EAACI Subcomittee on Allergen Standardization and Skin Tests. Position Paper: Allergen standardization and skin tests. Allergy 1993;48(suppl):48-82. IV
89. Position statement. Allergen skin testing. From the Board of Directors: J Allergy Clin Immunol 1993;92:636-7. IV
90. DREBORG S. Skin testing in allergen standardization and research. Dolen WK, editor. Skin Testing. Immunol Allergy Clinics N Am 2001;21:329-54. IV
91. AHLSTEDT S. Understanding the usefulness of specific IgE tests in allergy. Clin Exp Allergy 2002;32:11-6. IV
92. IV YMAN L. Standardization of in vitro methods. Allergy 2001;56(suppl 67):70-4. III
93. DOLEN WK. Skin testing and immunoassays for allergen-specific IgE: a workshop report. Ann Allergy Asthma Immunol 1999;82:407-12. IV
94. SANZ ML, PRIETO I, GARCIA BE et al. Diagnostic reliability considerations of specific IgE determination. J Invest Allergol Clin Immunol 1996;6:152-61. IV
95. DREBORG S. Diagnosis of food allergy: tests in vivo and in vitro. Pediatr Allergy Immunolol 2001;12(Suppl. 14):24-30. IV
96. KJELLMAN NM, JOHANSSON SG, ROTH A. Serum IgE levels in healthy children quantified by a sandwich technique (PRIST). Clin Allergy 1976;6(1):51-59. II
97. ZETTERSTROM O, JOHANSSON SG. IgE concentrations measured by PRIST in serum of healthy adults and in patients with respiratory allergy. A diagnostic approach. Allergy 1981;36(8):537-47. III
98. YUNGINGER JW, AHLSTEDT S, EGGLESTON PA et al. Quantitative IgE antibody assays in allergic diseases. J Allergy Clin Immunol 2000;105:1077-84. IV
99. NIGGEMANN B, WAHN U, SAMPSON HA. Proposals for standardization of oral food challenge tests in infants and children. Pediatr Allergy Immunol 1994;5:11-13. IV
100. EIGENMANN PA, SAMPSON HA. Interpreting skin prick tests in the evaluation of food allergy in children. Pediatr Allergy Immunol 1998;9(4):186-91. III
101. SAMPSON HA. Food allergy. Part 2: diagnosis and management. J Allergy Clin Immunol 1999;103:981-9. IV
102. SAMPSON HA. Utility of food-specific IgE concentrations in predicting symptomatic food allergy. J Allergy Clin Immunol 2001;107:891-6. II
103. SAMPSON HA, HO DG. Relationship between food-specific IgE concentrations and the risk of positive food challenges in children and adolescents. J Allergy Clin Immunol 1997;100:444-51. II
104. GARCIA-ARA C, BOYANO-MARTINEZ T, DIAZ-PENA JM, MARTIN-MUNOZ F, RECHE-FRUTOS M, MARTIN-ESTEBAN M. Specific IgE levels in the diagnosis of immediate hypersensitivity to cow's milk protein in the infant. J Allergy Clin Immunol 2001;107(1):185-0. II
105. BOYANO-MARTINEZ T, GARCIA-ARA C, DIAZ-PENA JM, MARTIN-ESTEBAN M. Prediction of tolerance on the basis of quantification of egg white-specific IgE antibodies in children with egg allergy. J Allergy Clin Immunol 2002;110(2):304-9.
106. MEDILLO G, AAS K, CARTIER A, DAVIES RJ, DEBELIC M, DREBORG S, KERREBIJN KF, LASSEN A, PINTO MENDES J, RIZZO A, ROSENTHAL RR, TATEISHI S, CORSICO R. Guidelines for the standardization of bronchial provocation test with allergens. Allergy 1991;46:321-329. IV
107. DREBORG S. Conjunctival Provocation Test (CPT). Allergy 1985;40(Suppl 4):66-7. IV
108. MOLLER C, BJORKSTEN B, NILSSON G, DREBORG S. The precision of the conjunctival provocation test. Allergy 1984;39(1):37-41. III
109. NOLTE H, SCHIØTZ O, Stahl Skov P. A new glass microfibre-based histamine analysis for allergy testing in children. Results compared with conventional leucocyte histamine release assay, skin prick test, bronchial provocation test and RAST. Allergy 1987;42:366-73. III
110. ØSTERGAARD PA, EBBESEN F, NOLTE H, STAHL SKOV P. Basophil histamine release in the diagnosis of house dust mite and dander allergy of asthmatic children. Comparison between prick test, RAST, basophil histamine release and bronchial provocation. Allergy 1990;45:1-5. III
111. ISOLAURI E, TURJANMAA K. Combined skin prick and patch testing enhances identification of food allergy in infants with atopic dermatitis. J Allergy Clin Immunol 1996;97:9-15. III
112. NIGGEMANN B, REIBEL S, WAHN U. The atopy patch test (APT) - a useful tool for the diagnosis of food allergy in children with atopic dermatitis. Allergy 2000;55:281-5. III
113. ROEHR CC, REIBEL S, ZIEGERT M, SOMMERFELD C, WAHN U, NIGGEMANN B. Atopy patch tests, together with determination of specific IgE levels, reduce the need for oral food challenges in children with atopic dermatitis. J Allergy Clin immunol 2001;107:548-553. III
114. VANTO T, JUNTUNEN-BACKMAN K, KALIMON K, KLEMOLA T, KOIVIKKO A, KOSKINEN P, SYVANEN P, VALOVIRTA E, VARJONEN E. The patch test, skin prick test, and serum milk-specific IgE as diagnostic tool in cow's milk allergy in infants. Allergy 1999;54(8):837-42. III
115. MUNIR AK, EINARSSON R, SCHOU C, DREBORG SK. Allergens in school dust I. The amount of the major cat (Fel d I) and dog (Can f I) allergens in dust from Swedish schools in high enough to probably cause persistent symptoms in most children with asthma who are sensitized to cat and dog. J Allergy Clin Immunolol 1993;91(5):1067-74. III